Differential regional and subtype-specific vulnerability of enteric neurons to mitochondrial dysfunction

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Viader, Andreu ^a   Wright Jin, Elizabeth C ^a   Vohra, Bhupinder P S ^a,b   Heuckeroth, Robert O ^a   Milbrandt, Jeffrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CENTRAL ARKANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL LOSS; CELL SUBPOPULATION; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GASTROINTESTINAL MOTILITY DISORDER; INTESTINE CELL; INTESTINE INNERVATION; MOUSE; NERVE CELL; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NITRERGIC NERVE; NONHUMAN; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL COUNT; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DNA REPLICATION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GENE DELETION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; GLIA; METABOLISM; MITOCHONDRION; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; MITOCHONDRIAL DNA; TFAM PROTEIN, MOUSE;

ANIMALS; AXONS; CELL COUNT; DISEASE SUSCEPTIBILITY; DNA REPLICATION; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GENE DELETION; GENE KNOCKOUT TECHNIQUES; HIGH MOBILITY GROUP PROTEINS; MICE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; NITRERGIC NEURONS; ORGAN SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 81155137294     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027727     Document Type: Article

References (44)

1. Pfeiffer RF, (2011) Gastrointestinal dysfunction in parkinson's disease. Parkinsonism Relat Disord 17 (1): 10-15 10.1016/j.parkreldis.2010.08.003.
2. Nussbaum RL, Ellis CE, (2003) Alzheimer's disease and parkinson's disease. N Engl J Med 348 (14): 1356-1364 10.1056/NEJM2003ra020003.
3. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, et al. (2001) Frequency of bowel movements and the future risk of parkinson's disease. Neurology 57 (3): 456-462.
4. Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, et al. (2007) Bowel movement frequency in late-life and incidental lewy bodies. Mov Disord 22 (11): 1581-1586 10.1002/mds.21560.
5. Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM, (1997) Constipation in parkinson's disease: Objective assessment and response to psyllium. Mov Disord 12 (6): 946-951 10.1002/mds.870120617.
6. Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, et al. (2006) Predictors of gastric emptying in parkinson's disease. Neurogastroenterol Motil 18 (5): 369-375 10.1111/j.1365-2982.2006.00780.x.
7. Kurlan R, Rothfield KP, Woodward WR, Nutt JG, Miller C, et al. (1988) Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility. Neurology 38 (3): 419-421.
8. Tomlinson DR, Gardiner NJ, (2008) Glucose neurotoxicity. Nat Rev Neurosci 9 (1): 36-45 10.1038/nrn2294.
9. Chandrasekharan B, Srinivasan S, (2007) Diabetes and the enteric nervous system. Neurogastroenterol Motil 19 (12): 951-960 10.1111/j.1365-2982.2007.01023.x.
10. Braak H, de Vos RA, Bohl J, Del Tredici K, (2006) Gastric alpha-synuclein immunoreactive inclusions in meissner's and auerbach's plexuses in cases staged for parkinson's disease-related brain pathology. Neurosci Lett 396 (1): 67-72 10.1016/j.neulet.2005.11.012.
11. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F, (1993) Lewy bodies in the visceral autonomic nervous system in parkinson's disease. Adv Neurol 60: 609-612.
12. Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF, (2010) Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 1802 (1): 122-134 10.1016/j.bbadis.2009.08.010.
13. Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, et al. (2007) Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A 104 (4): 1325-1330 10.1073/pnas.0605208103.
14. Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, et al. (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of parkinson's disease. Exp Neurol 207 (1): 4-12 10.1016/j.expneurol.2007.05.010.
15. Drolet RE, Cannon JR, Montero L, Greenamyre JT, (2009) Chronic rotenone exposure reproduces parkinson's disease gastrointestinal neuropathology. Neurobiol Dis 36 (1): 96-102 10.1016/j.nbd.2009.06.017.
16. Greene JG, Noorian AR, Srinivasan S, (2009) Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of parkinson's disease. Exp Neurol 218 (1): 154-161 10.1016/j.expneurol.2009.04.023.
17. Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, et al. (2008) Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of parkinson's disease. Neuroscience 153 (3): 634-644 10.1016/j.neuroscience.2008.02.033.
18. Hom XB, Lavine JE, (2004) Gastrointestinal complications of mitochondrial disease. Mitochondrion 4 (5-6): 601-607 10.1016/j.mito.2004.07.014.
19. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, et al. (1998) Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18 (3): 231-236 10.1038/ng0398-231.
20. Ekstrand MI, Falkenberg M, Rantanen A, Park CB, Gaspari M, et al. (2004) Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet 13 (9): 935-944 10.1093/hmg/ddh109.
21. Sorensen L, Ekstrand M, Silva JP, Lindqvist E, Xu B, et al. (2001) Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci 21 (20): 8082-8090.
22. Silva JP, Kohler M, Graff C, Oldfors A, Magnuson MA, et al. (2000) Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 26 (3): 336-340 10.1038/81649.
23. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, et al. (1999) Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 21 (1): 133-137 10.1038/5089.
24. Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, et al. (2002) Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci U S A 99 (23): 15066-15071 10.1073/pnas.232591499.
25. Viader A, Golden JP, Baloh RH, Schmidt RE, Hunter DA, et al. (2011) Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci 31 (28): 10128-10140 10.1523/JNEUROSCI.0884-11.2011.
26. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, et al. (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33 (3): 366-374 10.1038/ng1095.
27. Iwashita T, Kruger GM, Pardal R, Kiel MJ, Morrison SJ, (2003) Hirschsprung disease is linked to defects in neural crest stem cell function. Science 301 (5635): 972-976 10.1126/science.1085649.
28. Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG, (2001) Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci U S A 98 (7): 4038-4043 10.1073/pnas.061038798.
29. Phillips RJ, Hargrave SL, Rhodes BS, Zopf DA, Powley TL, (2004) Quantification of neurons in the myenteric plexus: An evaluation of putative pan-neuronal markers. J Neurosci Methods 133 (1-2): 99-107.
30. Ilieva H, Polymenidou M, Cleveland DW, (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187 (6): 761-772 10.1083/jcb.200908164.
31. Wood JD, Alpers DH, Andrews PL, (1999) Fundamentals of neurogastroenterology. Gut 45 (Suppl 2): II6-II16.
32. Sang Q, Young HM, (1996) Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse. Cell Tissue Res 284 (1): 39-53.
33. Coleman M, (2005) Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 6 (11): 889-898 10.1038/nrn1788.
34. Furness JB, (2006) The enteric nervous system. Massachussetts Wiley-Blackwell.
35. Pickrell AM, Fukui H, Wang X, Pinto M, Moraes CT, (2011) The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci 31 (27): 9895-9904 10.1523/JNEUROSCI.6223-10.2011.
36. Cellek S, Foxwell NA, Moncada S, (2003) Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52 (9): 2353-2362.
37. Hao MM, Moore RE, Roberts RR, Nguyen T, Furness JB, et al. (2010) The role of neural activity in the migration and differentiation of enteric neuron precursors. Neurogastroenterol Motil 22 (5): e127-37 10.1111/j.1365-2982.2009.01462.x.
38. Dufour E, Terzioglu M, Sterky FH, Sorensen L, Galter D, et al. (2008) Age-associated mosaic respiratory chain deficiency causes trans-neuronal degeneration. Hum Mol Genet 17 (10): 1418-1426 10.1093/hmg/ddn030.
39. Lowell BB, Shulman GI, (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307 (5708): 384-387 10.1126/science.1104343.
40. Wiskur B, Greenwood-Van Meerveld B, (2010) The aging colon: The role of enteric neurodegeneration in constipation. Curr Gastroenterol Rep 12 (6): 507-512 10.1007/s11894-010-0139-7.
41. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4.
42. Neuhuber WL, Worl J, Berthoud HR, Conte B, (1994) NADPH-diaphorase-positive nerve fibers associated with motor endplates in the rat esophagus: New evidence for co-innervation of striated muscle by enteric neurons. Cell Tissue Res 276 (1): 23-30.
43. Schafer KH, Klotz M, Mergner D, Mestres P, Schimrigk K, et al. (2000) IgG-mediated cytotoxicity to myenteric plexus cultures in patients with paraneoplastic neurological syndromes. J Autoimmun 15 (4): 479-484 10.1006/jaut.2000.0454.
44. Nagarajan R, Svaren J, Le N, Araki T, Watson M, et al. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30 (2): 355-368.